BIOMAT Database Logo BIOMAT Database Logo

Sentinel lymph nodes in melanoma patients: evaluating the evidence. 2006

Vincenzo De Giorgi, and Genny Leporatti, and Daniela Massi, and Giulia Lo Russo, and Serena Sestini, and Federica Papi, and Mario Dini, and Torello Lotti

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease
D019317 Evidence-Based Medicine An approach of practicing medicine with the goal to improve and evaluate patient care. It requires the judicious integration of best research evidence with the patient's values to make decisions about medical care. This method is to help physicians make proper diagnosis, devise best testing plan, choose best treatment and methods of disease prevention, as well as develop guidelines for large groups of patients with the same disease. (from JAMA 296 (9), 2006) Medicine, Evidence-Based,Evidence Based Medicine,Medicine, Evidence Based
D021701 Sentinel Lymph Node Biopsy A diagnostic procedure used to determine whether LYMPHATIC METASTASIS has occurred. The SENTINEL LYMPH NODE is the first lymph node to receive drainage from a neoplasm. Biopsy, Sentinel Lymph Node,Lymph Node Biopsy, Sentinel

Related Publications

Vincenzo De Giorgi, and Genny Leporatti, and Daniela Massi, and Giulia Lo Russo, and Serena Sestini, and Federica Papi, and Mario Dini, and Torello Lotti
Interval sentinel lymph nodes in melanoma.
May 2002, Archives of surgery (Chicago, Ill. : 1960),
Vincenzo De Giorgi, and Genny Leporatti, and Daniela Massi, and Giulia Lo Russo, and Serena Sestini, and Federica Papi, and Mario Dini, and Torello Lotti
Sentinel Lymph Nodes in Cutaneous Melanoma.
September 2017, Clinics in laboratory medicine,
Vincenzo De Giorgi, and Genny Leporatti, and Daniela Massi, and Giulia Lo Russo, and Serena Sestini, and Federica Papi, and Mario Dini, and Torello Lotti
[Sentinel lymph nodes in skin melanoma].
January 2000, Annali italiani di chirurgia,
Vincenzo De Giorgi, and Genny Leporatti, and Daniela Massi, and Giulia Lo Russo, and Serena Sestini, and Federica Papi, and Mario Dini, and Torello Lotti
Sentinel lymph nodes in cutaneous melanoma.
June 2011, Clinics in laboratory medicine,
Vincenzo De Giorgi, and Genny Leporatti, and Daniela Massi, and Giulia Lo Russo, and Serena Sestini, and Federica Papi, and Mario Dini, and Torello Lotti
Sentinel Lymph Nodes in Cutaneous Melanoma.
September 2009, Surgical pathology clinics,
Vincenzo De Giorgi, and Genny Leporatti, and Daniela Massi, and Giulia Lo Russo, and Serena Sestini, and Federica Papi, and Mario Dini, and Torello Lotti
Survivin expression in sentinel lymph nodes from melanoma patients.
July 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Vincenzo De Giorgi, and Genny Leporatti, and Daniela Massi, and Giulia Lo Russo, and Serena Sestini, and Federica Papi, and Mario Dini, and Torello Lotti
Langerhans Cells in Sentinel Lymph Nodes from Melanoma Patients.
May 2024, Cancers,
Vincenzo De Giorgi, and Genny Leporatti, and Daniela Massi, and Giulia Lo Russo, and Serena Sestini, and Federica Papi, and Mario Dini, and Torello Lotti
Pathologic examination of sentinel lymph nodes from melanoma patients.
May 2008, Seminars in diagnostic pathology,
Vincenzo De Giorgi, and Genny Leporatti, and Daniela Massi, and Giulia Lo Russo, and Serena Sestini, and Federica Papi, and Mario Dini, and Torello Lotti
Compartmentalizing sentinel lymph nodes and nonsentinel lymph nodes in regional lymph nodes draining the primary melanoma.
September 2013, JAMA surgery,
Vincenzo De Giorgi, and Genny Leporatti, and Daniela Massi, and Giulia Lo Russo, and Serena Sestini, and Federica Papi, and Mario Dini, and Torello Lotti
Completion lymph node dissection in melanoma patients with positive sentinel lymph nodes.
October 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
Copied contents to your clipboard!